ACM

Altium Capital Management Portfolio holdings

AUM $34.4M
This Quarter Return
+27.24%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
+$195M
Cap. Flow
-$107M
Cap. Flow %
-54.62%
Top 10 Hldgs %
44.8%
Holding
156
New
23
Increased
14
Reduced
15
Closed
62

Top Buys

1
ATXS icon
Astria Therapeutics
ATXS
$13.6M
2
REPL icon
Replimune Group
REPL
$4.35M
3
TNDM icon
Tandem Diabetes Care
TNDM
$4.05M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
$3.88M
5
OTLK icon
Outlook Therapeutics
OTLK
$3.59M

Top Sells

1
CCXI
ChemoCentryx, Inc.
CCXI
$8.27M
2
INSM icon
Insmed
INSM
$5.77M
3
MBTC
Nocturne Acquisition Corporation Ordinary Shares
MBTC
$5.17M
4
VRNA
Verona Pharma
VRNA
$4.94M
5
CBAY
Cymabay Therapeutics
CBAY
$4.55M

Sector Composition

1 Healthcare 89.27%
2 Financials 5.84%
3 Communication Services 0.42%
4 Industrials 0.37%
5 Materials 0.3%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NVRO
26
DELISTED
NEVRO CORP.
NVRO
$3.01M 1.53%
76,000
+12,000
+19% +$475K
PACB icon
27
Pacific Biosciences
PACB
$378M
$2.99M 1.52%
+365,000
New +$2.99M
BHVN icon
28
Biohaven
BHVN
$1.71B
$2.78M 1.41%
+200,000
New +$2.78M
CTIC
29
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.7M 1.37%
450,000
+23,000
+5% +$138K
SIBN icon
30
SI-BONE Inc
SIBN
$700M
$2.65M 1.35%
195,000
+28,000
+17% +$381K
NEO icon
31
NeoGenomics
NEO
$1.06B
$2.63M 1.34%
+285,000
New +$2.63M
TVRD
32
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
$2.1M 1.07%
195,960
+2,960
+2% +$31.7K
NBIX icon
33
Neurocrine Biosciences
NBIX
$13.5B
$2.09M 1.06%
17,500
-1,500
-8% -$179K
COLL icon
34
Collegium Pharmaceutical
COLL
$1.25B
$2.09M 1.06%
90,000
-26,000
-22% -$603K
PCVX icon
35
Vaxcyte
PCVX
$4.17B
$2.06M 1.05%
+43,000
New +$2.06M
TGVCU
36
DELISTED
TG Venture Acquisition Corp. Units
TGVCU
$2.04M 1.04%
200,000
– –
PLRX icon
37
Pliant Therapeutics
PLRX
$105M
$1.93M 0.98%
100,000
-115,000
-53% -$2.22M
SAGE
38
DELISTED
Sage Therapeutics
SAGE
$1.91M 0.97%
+50,000
New +$1.91M
BLRX
39
BioLineRX
BLRX
$15.5M
$1.83M 0.93%
3,103,635
-1,045,627
-25% -$617K
ADRT
40
DELISTED
Ault Disruptive Technologies Corporation
ADRT
$1.54M 0.78%
150,000
– –
SYRS
41
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.13M 0.57%
+315,070
New +$1.13M
WAVSU
42
DELISTED
Western Acquisition Ventures Corp. Unit
WAVSU
$1.1M 0.56%
100,000
– –
MURFU
43
DELISTED
Murphy Canyon Acquisition Corp. Unit
MURFU
$1.02M 0.52%
100,000
– –
ARYD
44
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.01M 0.51%
100,000
– –
MITA
45
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$853K 0.43%
85,000
– –
TSHA icon
46
Taysha Gene Therapies
TSHA
$791M
$811K 0.41%
+359,051
New +$811K
SLGC
47
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$778K 0.4%
+310,000
New +$778K
HYRE
48
DELISTED
HyreCar Inc. Common Stock
HYRE
$716K 0.36%
+1,688,120
New +$716K
TERN icon
49
Terns Pharmaceuticals
TERN
$651M
$713K 0.36%
+70,000
New +$713K
FATBW
50
DELISTED
FAT Brands Inc. Warrant
FATBW
$683K 0.35%
227,000
– –
1
2
3 4 5